Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

New England Journal of Medicine - Tập 365 Số 10 - Trang 883-891 - 2011
Manesh R. Patel1, Kenneth W. Mahaffey1, Jyotsna Garg1, Guohua Pan2, Daniel E. Singer3, Anna Falanga4, Günter Breithardt5, Jonathan L. Halperin6, Graeme J. Hankey7, Jonathan P. Piccini1, Richard C. Becker1, Christopher C. Nessel2, John F. Paolini8, Scott D. Berkowitz8, Robert M. Califf9
1Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
2Johnson & Johnson Pharmaceutical Research and Development, Raritan
3Massachusetts General Hospital and Harvard Medical School — both in Boston
4Ruprecht-Karls-University Heidelberg
5Hospital of the University of Münster, Münster
6Cardiovascular Institute, Mount Sinai Medical Center, New York
7Royal Perth Hospital, Perth, WA, Australia
8Bayer HealthCare Pharmaceuticals, Montville
9University of Edinburgh and Royal Infirmary of Edinburgh — both in Edinburgh

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1161/01.STR.22.8.983

10.1001/archinte.147.9.1561

10.7326/0003-4819-131-7-199910050-00003

10.7326/0003-4819-146-12-200706190-00007

10.1378/chest.126.3_suppl.429S

10.1001/archinte.156.20.2311

10.7326/0003-4819-131-12-199912210-00004

10.1016/j.jacc.2009.04.091

10.1007/s00228-005-0043-5

10.1185/03007990802361499

10.1056/NEJMoa0800374

10.1056/NEJMoa076016

10.1056/NEJMoa1007903

10.1001/jama.293.6.690

10.1002/sim.2244

10.1002/sim.1934

10.1001/jama.295.10.1152

10.1002/sim.3462

Rosendaal FR, 1993, Thromb Haemost, 69, 236, 10.1055/s-0038-1651587

10.1016/S0140-6736(06)68845-4

10.1056/NEJMoa0905561

10.1161/CIRCOUTCOMES.110.957738

10.1016/S0140-6736(10)61194-4

Thông tin
Thông tin xuất bản

New England Journal of Medicine

Tập 365 Số 10

883-891

Thông tin tác giả